1. DIGITAL.CSIC

Esteban, Mariano

Colaboraciones Ver estadísticas de uso Alertas por Email RSS

Perfil

descarga.jpg picture
 
Firma en Digital.CSIC (*)
Esteban, Mariano
 
Centro o Instituto
CSIC - Centro Nacional de Biotecnología (CNB)
 
Departamento
Biología molecular y celular
 
Categoría Profesional
Profesor de Investigación
 
Especialización
Poxvirus y Vacunas
 
Email
mesteban@cnb.csic.es
 
ORCID
 
Perfil en Google Scholar
 
Scopus AuthorID
 
Otros - ResearchGate
 
Otros identificadores (con url)
 

Publications

Refined By:
Fulltext:  With Fulltext

Resultados 1-20 de 84.

DerechosPreviewFecha Public.TítuloAutor(es)Tipo
1openAccessGarcía-Arriaza et al., 2011. PLoS ONE.pdf.jpg2011A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responsesGarcía-Arriaza, Juan CSIC ORCID ; Nájera, José Luis; Gómez, Carmen E. CSIC ORCID; Tewabe, Nolawit; Sorzano, Carlos Oscar S; Calandra, Thierry; Roger, Thierry; Esteban, Mariano CSIC ORCID artículo
2openAccessComparative Phase I Study of Combination.pdf.jpg22-feb-2017A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization RegimesJoseph, Sarah; Esteban, Mariano CSIC ORCID ; Weber, Jonathanartículo
3openAccessviruses-11-00160.pdf.jpg16-feb-2019A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody ResponsesPerdiguero, Beatriz; Sánchez-Corzo, Cristina; Sorzano, Carlos Óscar S.; Saiz, Lidia; Mediavilla, Pilar; Esteban, Mariano CSIC ORCID ; Gómez, Carmen E. CSIC ORCIDartículo
4openAccess41. Viruses 2019. MVA-GP145-GPN.pdf.jpg16-feb-2019A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody ResponsesPerdiguero, Beatriz; Sánchez-Corzo, Cristina; Sorzano, Carlos Oscar S; Saiz, Lidia; Mediavilla, Pilar; Esteban, Mariano CSIC ORCID ; Gómez, Carmen E. CSIC ORCIDartículo
5openAccessGarcía-Arriaza et al., 2014. MVA-CHIKV. J. Virol..pdf.jpgmar-2014A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infectionGarcía-Arriaza, Juan CSIC ORCID ; Cepeda, Victoria; Hallengärd, David; Sorzano, Carlos Óscar S; Kümmerer, Beate Mareike; Liljeström, Peter; Esteban, Mariano CSIC ORCID artículo
6openAccessfimmu-12-824728.pdf.jpg27-ene-2022A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 InfectionPérez, Patricia; Lázaro-Frías, Adrián; Zamora, Carmen; Sánchez-Cordón, P. J.; Astorgano, David; Luczkowiak, Joanna; Delgado, Rafael; Casasnovas, José María CSIC ORCID ; Esteban, Mariano CSIC ORCID ; García-Arriaza, Juan CSIC ORCID artículo
7openAccessRN5.pdf.jpg2018A vaccine based on a modified vaccinia virus Ankara vector expressing Zika virus structural proteins controls Zika virus replication in micePérez, Patricia; Marín, María Q.; Lázaro-Frías, Adrián; Jiménez de Oya, Nereida; Blázquez, Ana B.; Escribano-Romero, Estela; Sorzano, Carlos Óscar S.; Ortego, Javier; Saiz Calahorra, Juan Carlos; Esteban, Mariano CSIC ORCID ; Martín-Acebes, M. A.; García-Arriaza, Juan CSIC ORCID artículo
8openAccessjournal.pone.0006422.pdf.jpg30-jun-2009Activation of NF-kB Pathway by Virus Infection Requires Rb ExpressionGarcía, María A.; Gallego, Pedro; Campagna, Michela; González-Santamaría, José CSIC; Esteban, Mariano CSIC ORCID ; Rivas, Carmenartículo
9openAccesszpq2046.pdf.jpg12-feb-2008Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenicCorbett, Max; Bogers, Willy M; Heeney, Jonathan L; Gerber, Stefan; Genin, Christian; Didierlaurent, Arnaud; Oostermeijer, Herman; Dubbes, Rob; Braskamp, Gerco; Lerondel, Stéphanie; Gómez, Carmen E. CSIC ORCID; Esteban, Mariano CSIC ORCID ; Wagner, Ralf; Kondova, Ivanella; Mooij, Petra; Balla-Jhagjhoorsingh, Sunita; Beenhakker, Niels; Koopman, Gerrit; van der Burg, Sjoerd; Kraehenbuhl, Jean-Pierre; Le Pape, Alainartículo
10openAccessNajera JL C7L JVI 2006.pdf.jpgjun-2006Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L geneNájera, José Luis; Gómez, Carmen E. CSIC ORCID; Domingo-Gil, Elena; Gherardi, María Magdalena; Esteban, Mariano CSIC ORCID artículo
11openAccessJournal of Virology-2021-García-Arriaza-JVI.02260-20.full.pdf.jpg7-ene-2021COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in miceGarcía-Arriaza, Juan CSIC ORCID ; Garaigorta, Urtzi ; Pérez, Patricia; Lázaro-Frías, Adrián; Zamora, Carmen; Gastaminza, Pablo CSIC ORCID; Fresno, Carlos del; Casasnovas, José María CSIC ORCID ; Sorzano, Carlos Óscar S.; Sancho, David; Esteban, Mariano CSIC ORCID artículo
12openAccessSituación actual_Alcami.pdf.jpgjul-2005Current situation in the development of a preventive HIV vaccineAlcamí, José CSIC ORCID; Munné, J. J.; Muñoz-Fernández, María Ángeles CSIC ORCID; Esteban, Mariano CSIC ORCID artículo
13openAccessGarcía-Arriaza et al., 2014. MVA-B dN2L. J. Virol..pdf.jpgmar-2014Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigensGarcía-Arriaza, Juan CSIC ORCID ; Gómez, Carmen E. CSIC ORCID; Sorzano, Carlos Óscar S; Esteban, Mariano CSIC ORCID artículo
14openAccessDeletion_Perez_Art2020.pdf.jpg2020Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-BPérez, Patricia; Marín, María Q.; Lázaro-Frías, Adrián; Sorzano, Carlos Óscar S.; Gómez, Carmen E. CSIC ORCID; Esteban, Mariano CSIC ORCID ; García-Arriaza, Juan CSIC ORCID artículo
15openAccessAdvanced Science - 2023 - L zaro‐Gorines - Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody.pdf.jpg20-oct-2023Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2Lázaro-Gorines, Rodrigo; Pérez, Patricia; Heras-Murillo, Ignacio; Adán-Barrientos, Irene; Albericio, Guillermo; Astorgano, David; Flores, Sara; Luczkowiak, Joanna; Labiod, Nuria; Harwood, Seandean Lykke; Segura-Tudela, Alejandro; Rubio-Pérez, Laura CSIC; Nugraha, Yudhi; Shang, Xiaoran; Li, Yuxing; Alfonso, Carlos CSIC ORCID ; Adipietro, Kaylin A.; Abeyawardhane, Dinendra L.; Navarro, Rocío; Compte, Marta; Yu, Wenbo; MacKerell Jr., Alexander D.; Sanz, Laura CSIC ORCID; Weber, David J.; Blanco, Francisco J. CSIC ; Esteban, Mariano CSIC ORCID ; Pozharski, Edwin; Godoy-Ruiz, Raquel; Muñoz, Inés G.; Delgado, Rafael; Sancho, David; García-Arriaza, Juan CSIC ORCID ; Álvarez-Vallina, Luisartículo
16openAccessLázaro-Frías et al., 2018. J. Virol..pdf.jpg1-jun-2018Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 ProteinsLázaro-Frías, Adrián; Gómez-Medina, Sergio; Sánchez-Sampedro, Lucas; Ljungberg, Karl; Ustav, Mart; Liljeström, Peter; Muñoz-Fontela, César; Esteban, Mariano CSIC ORCID ; García-Arriaza, Juan CSIC ORCID artículo
17openAccessDistinct p21 requirements....pdf.jpg9-ene-2015Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production.Daszkiewicz, Lidia; Vázquez-Mateo, C.; Ballesteros-Tato, A.; Weber, K.; Madrigal-Avilés, A.; Di Pilato, Mauro; Fotedar, A.; Fotedar, R.; Flores, J.M.; Esteban, Mariano CSIC ORCID ; Martínez-A, Carlos CSIC ORCID; Balomenos, Dimitrios CSIC ORCID CVN artículo
18openAccessVentoso Ivan Diversity in viral.pdf.jpgfeb-2011Diversity in viral anti-PKR mechanisms: A remarkable case of evolutionary convergenceDomingo-Gil, Elena; Toribio, René CSIC ORCID; Nájera García, José Luis; Esteban, Mariano CSIC ORCID ; Ventoso, Iván CSIC ORCIDartículo
19openAccessÖhlund et al., 2018. Scientific Reports.pdf.jpg20-ago-2018DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boostÖhlund, Pontus; García-Arriaza, Juan CSIC ORCID ; Zusinaite, Eva; Szurgot, Inga; Männik, Andres; Kraus, Annette; Ustav, Mart; Merits, Andres; Esteban, Mariano CSIC ORCID ; Liljeström, Peter; Ljungberg, Karlartículo
20openAccessvaccines-09-00243.pdf.jpg11-mar-2021Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19Gómez, Carmen E. CSIC ORCID; Perdiguero, Beatriz; Esteban, Mariano CSIC ORCID artículo